Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NF-κB Signalling in Glioblastoma
Vincent Soubannier, Stefano Stifani
Biomedicines (2017) Vol. 5, Iss. 2, pp. 29-29
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Advancement of NF-κB Signaling Pathway: A Novel Target in Pancreatic Cancer
Kartick C. Pramanik, Monish Ram Makena, Kuntal Bhowmick, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 3890-3890
Open Access | Times Cited: 120
Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review
Keywan Mortezaee, Masoud Najafi, Bagher Farhood, et al.
Life Sciences (2019) Vol. 228, pp. 228-241
Closed Access | Times Cited: 116
A Role for NF-κB in Organ Specific Cancer and Cancer Stem Cells
Christian Kaltschmidt, Constanze Banz‐Jansen, Tahar Benhidjeb, et al.
Cancers (2019) Vol. 11, Iss. 5, pp. 655-655
Open Access | Times Cited: 90
NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways
Naze G. Avci, Sadaf Ebrahimzadeh-Pustchi, Yasemin M. Akay, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 62
Pre-clinical tumor models of primary brain tumors: Challenges and opportunities
Farhana Akter, Brennan Simon, Nadine L. de Boer, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1875, Iss. 1, pp. 188458-188458
Open Access | Times Cited: 59
The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma
Laura-Marie Ammer, Arabel Vollmann‐Zwerenz, Viktoria Ruf, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 2973-2973
Open Access | Times Cited: 50
Noscapine, an Emerging Medication for Different Diseases: A Mechanistic Review
Pouria Rahmanian‐Devin, Vafa Baradaran Rahimi, Mahmoud Reza Jaafari, et al.
Evidence-based Complementary and Alternative Medicine (2021) Vol. 2021, pp. 1-16
Open Access | Times Cited: 44
Fluoride in the Central Nervous System and Its Potential Influence on the Development and Invasiveness of Brain Tumours—A Research Hypothesis
Wojciech Żwierełło, Agnieszka Maruszewska, Marta Skórka-Majewicz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1558-1558
Open Access | Times Cited: 18
Noscapine, a Non-addictive Opioid and Microtubule-Inhibitor in Potential Treatment of Glioblastoma
Meric A. Altinöz, Gülaçtı Topçu, Ahmet Hacımüftüoğlu, et al.
Neurochemical Research (2019) Vol. 44, Iss. 8, pp. 1796-1806
Closed Access | Times Cited: 48
The Bradykinin-BDKRB1 Axis Regulates Aquaporin 4 Gene Expression and Consequential Migration and Invasion of Malignant Glioblastoma Cells via a Ca2+-MEK1-ERK1/2-NF-κB Mechanism
Ding‐Ping Sun, Yuan‐Wen Lee, Jui‐Tai Chen, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 667-667
Open Access | Times Cited: 40
Cannabidiol converts NF-κB into a tumor suppressor in glioblastoma with defined antioxidative properties
Marie N.M. Volmar, Jiying Cheng, Haitham Alenezi, et al.
Neuro-Oncology (2021) Vol. 23, Iss. 11, pp. 1898-1910
Open Access | Times Cited: 39
Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients
Susannah Hallal, Saeideh Ebrahim Khani, Heng Wei, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4954-4954
Open Access | Times Cited: 37
TLR-4 Signaling vs. Immune Checkpoints, miRNAs Molecules, Cancer Stem Cells, and Wingless-Signaling Interplay in Glioblastoma Multiforme—Future Perspectives
Jakub Litak, Cezary Grochowski, Joanna Litak, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3114-3114
Open Access | Times Cited: 35
Anti-glioblastoma effects of nanomicelle-curcumin plus erlotinib
Reza Bagherian, Bostan Roudi, Nahid Masoudian, et al.
Food & Function (2021) Vol. 12, Iss. 21, pp. 10926-10937
Closed Access | Times Cited: 28
Harnessing oxidative stress for anti-glioma therapy
Robert P. Ostrowski, Emanuela Pucko
Neurochemistry International (2022) Vol. 154, pp. 105281-105281
Closed Access | Times Cited: 22
PLGA–Nano-Encapsulated Disulfiram Inhibits Hypoxia-Induced NF-κB, Cancer Stem Cells, and Targets Glioblastoma In Vitro and In Vivo
Vinodh Kannappan, Ying Liu, Zhipeng Wang, et al.
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 8, pp. 1273-1284
Open Access | Times Cited: 20
The transmembrane proteins (TMEM) and their role in cell proliferation, migration, invasion, and epithelial-mesenchymal transition in cancer
Gloria Angelina Herrera-Quiterio, Sergio Encarnación
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment
Mahdie Rahban, Sara Joushi, Hamideh Bashiri, et al.
Frontiers in Chemistry (2024) Vol. 11
Open Access | Times Cited: 4
METTL8 links mt-tRNA m3C modification to the HIF1α/RTK/Akt axis to sustain GBM stemness and tumorigenicity
Bernice Woon Li Lee, You Heng Chuah, Jeehyun Yoon, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 4
Glycosylated Delphinidins Decrease Chemoresistance to Temozolomide by Regulating NF-κB/MGMT Signaling in Glioblastoma
Diego Carrillo-Beltrán, Yéssica Nahuelpán, Clara Santos‐Cuevas, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 179-179
Open Access
A systematic and comprehensive review of the properties and synthesis of anticancer heterocyclic natural products
Tirth Chauhan, Manan Shah
Current Pharmaceutical Analysis (2025)
Open Access
Enhanced Intranasal Delivery of Atorvastatin via Superparamagnetic Iron-Oxide-Loaded Nanocarriers: Cytotoxicity and Inflammation Evaluation and In Vivo, In Silico, and Network Pharmacology Study for Targeting Glioblastoma Management
Kristina Zarif Attalla, Doaa H. Hassan, Mahmoud H. Teaima, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 421-421
Open Access
Therapeutic Potential of NF-κB Inhibition in Glioblastoma: Gene Therapy Approach with rAAV-5 Mediated IκBαM Overexpression
Ceera Manikandan, Amit Kumar Jaiswal
Molecular Biotechnology (2025)
Closed Access
Assessing the diagnostic, prognostic, and therapeutic potential of the somatostatin/cortistatin system in glioblastoma
Miguel E. G-García, Ana S De la Rosa-Herencia, Álvaro Flores‐Martínez, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Inhibition of glioblastoma cell proliferation, invasion, and mechanism of action of a novel hydroxamic acid hybrid molecule
Issan Zhang, Maja Beus, Ursula Stochaj, et al.
Cell Death Discovery (2018) Vol. 4, Iss. 1
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top